Bhatt Nailesh has filed 6 insider transactions across 2 companies since December 2023.
Most recent transaction: a grant/award of 2455 shares of Hyperliquid Strategies Inc ($PURR) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Hyperliquid Strategies Inc | $PURR | Bhatt Nailesh | Not found | A | Common Stock | 2455 | $0.00 | 45,326.0000 | 124,093,048 | 5.73% | 0.00% |
| Feb. 9, 2026 | Hyperliquid Strategies Inc | $PURR | Bhatt Nailesh | Not found | A | Common Stock | 40789 | $0.00 | 42,871.0000 | 124,093,048 | 1959.13% | 0.03% |
| Dec. 2, 2025 | Hyperliquid Strategies Inc | $PURR | Bhatt Nailesh | Not found | J | Common Stock | 2082 | $0.00 | 2,082.0000 | 0 | 9999.99% | 0.00% |
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Bhatt Nailesh | Director | D | Common Stock | 10547 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.15% |
| July 11, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Bhatt Nailesh | Director | A | Common Stock | 10000 | $0.00 | 10,547.0000 | 3,332,728 | 1828.15% | 0.30% |
| Dec. 11, 2023 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Bhatt Nailesh | Director | A | Common Stock | 373 | $0.00 | 547.0000 | 0 | 214.37% | 0.00% |